KELLIE MARQUIS: Open Payments
NPI 1730672262 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,810 in 115 payments from 16 companies in 2025. Trend: 2023 $1,116 · 2024 $1,654 · 2025 $1,810
Food & beverage: $1,810
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 32 | $393 |
| PFIZER INC. | 14 | $216 |
| Merck Sharp & Dohme LLC | 10 | $196 |
| CVRx, Inc. | 8 | $166 |
| Amgen Inc. | 13 | $140 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $139 |
| Kestra Medical Technology Services, Inc. | 5 | $132 |
| Alnylam Pharmaceuticals Inc. | 5 | $92 |
| BridgeBio Pharma, Inc. | 3 | $67 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $66 |
Products named: LEQVIO, VERQUVO, Barostim Neo System, VYNDAQEL, REPATHA, JARDIANCE, Assure WCD, AMVUTTRA.
Industry payments across AZ — which companies pay providers there.
